Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to the Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of Related Party Transactions on a Standalone basis, in the format specified in the relevant accounting standards for the half year ended on March 31, 2022. Request you to take the above on record and acknowledge
06-06-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24 A of SEBI (Listing Obligations and Disclosure Requirements} Regulations 2015, the Annual Secretarial Compliance Audit was carried out by M/s. SPNP and Associates, Practicing Company Secretaries, for the financial year ended 31/03/2022 and the report issued by them is enclosed herewith for your records.
27-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 read with Para A of Part A of schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the Investor Presentation for the quarter and year ended 31st March 2022.
25-05-2022
Bigul

Annual report for Amrutanjan Health Care Ltd. for FY-2022
25-05-2022
Bigul

Amrutanjan posts 67 crore profit in FY22
24-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board recommends Final Dividend

 Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.
24-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Results - Financial Results For March 31, 2022

 In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 24, 2022) had inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2022, as recommended by the Audit Committee at its meeting held today (May 24 2022) The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.
24-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting

 In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 24, 2022) had inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2022, as recommended by the Audit Committee at its meeting held today (May 24 2022) The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.
24-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board to consider Final Dividend

 Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on May 24, 2022 thru video Conferencing to consider and approve, inter-alia :1. Audited Financial Results along with the Audit Report by the statutory Auditors for the quarter and year ended March 31, 2022.2. Declaration of Final Dividend for the financial year 2021-22; if any.Further, as already informed vide the Company''s letter dt. March 30, 2022, the Trading window for dealing in equity shares of the company is closed effective from April 01, 2022 and will remain closed till May 26, 2022 pursuant to SEBI (PIT) Regulations, 2015 and in terms of Code of Conduct to regulate, monitor and report trading in securities of the Company.
17-05-2022
Bigul

AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Intimation for Intimation Under Regulation Zg(L) Of Sebi (Listing Obligations Requirements) & Disclosure Regulations, 201S (SEBI IODR)

 AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 ,inter alia, to consider and approve Pursuant to the above mentioned regulation of SEBI LODR, we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday the 24th May,2022 thru video Conferencing to consider and approve, inter-alia, (i) Audited Financial Results along with the Audit Report by the statutory Auditors for the quarter and year ended March 3I 2022. (ii)Declaration of Final Dividend for the financial year 2021-22; if any It may also be noted that as already informed vide our letter dt. 30tI, March 2022,the Trading window for dealing in equity shares of the company is closed effective from 1st April, 2022 and will remain closed till 26tr'' May 2022 pursuant to SEBI (PIT) Regulations, 2015 and in terms of Code of Conduct to regulate, monitor and report trading in securities of the Company. Request to take the above on record and acknowledge.
17-05-2022
Next Page
Close

Let's Open Free Demat Account